JPRN-UMIN000002959
Completed
Phase 4
Plaque REgression with Cholesterol absorption Inhibitor or Synthesis inhibitor Evaluated by IntraVascular UltraSound - The PRECISE-IVUS trial
Department of Cardiovascular Medicine, Graduate School of Medical Sciences, Kumamoto University0 sites300 target enrollmentJanuary 6, 2010
Overview
- Phase
- Phase 4
- Intervention
- Not specified
- Conditions
- patients aged 30-85 years who were undergoing percutaneous coronary intervention (PCI, elective or emergency) with >
- Sponsor
- Department of Cardiovascular Medicine, Graduate School of Medical Sciences, Kumamoto University
- Enrollment
- 300
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •\- Familial hypercholesterolemia \- Being treated with Zetia (Ezetimibe) \- Being treated with Fibrates \- Renal insufficiency (serum creatinine \>\= 2\.0 mg/dl) \- Altered hepatic function (serum aspartate aminotransferase or alanine aminotransferase \>\= 3\-folds of standard value in each institute) \- Undergoing hemodialysis or peritoneal dialysis \- Allergic to Lipitor and/or Zetia \- Severe underlying disease \- Lack of decision\-making capacity \- Recognized as inadequate by attending doctor
Outcomes
Primary Outcomes
Not specified
Similar Trials
Not yet recruiting
Phase 3
A clinical trial to compare the effects of an Unani Toothpaste with Herbo-mineral Toothpaste in patients with infection of gums that support the teethHealth Condition 1: K089- Disorder of teeth and supporting structures, unspecifiedCTRI/2023/03/050322Central Council for Research in Unani Medicine CCRUM New Delhi
Not yet recruiting
Phase 2
Comparative Study to Compare Safetyand Efficacy of an Unani Toothpaste with Herbo-mineral Toothpaste inPatients with AmrÄ?d Al-AsnÄ?n-o-Litha (Periodontal Diseases)CTRI/2023/03/050532Central Council for Research in Unani Medicine
Active, not recruiting
Phase 1
Clinical trial on the efficacy and safety of bemiparin in patients hospitalized because of COVID-19EUCTR2020-001548-24-ESFundación de Investigación HM Hospitales120
Not yet recruiting
Phase 2
Treatment of Bronchial Asthma (Zeequn Nafas) with Unani MedicineHealth Condition 1: J989- Respiratory disorder, unspecifiedCTRI/2023/01/048733Central Council for Research in Unani Medicine
Not yet recruiting
Phase 3
A clinical trial to compare the effects of Unani research drug Cap Nazla with allopathic drug Tablet Levocetirizine in patients with Common coldCTRI/2022/11/047772Central Council for Research in Unani Medicine (CCRUM), New Delhi